Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001851654 | SCV002245451 | pathogenic | Charcot-Marie-Tooth disease type 2 | 2021-03-23 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Tyr213Thrfs*20) in the BSCL2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BSCL2 are known to be pathogenic (PMID: 11479539, 23564749). This variant is present in population databases (rs758843908, ExAC 0.01%). This variant has been observed in individual(s) with Berardinelli–Seip congenital lipodystrophy (PMID: 11479539, 23659685). This variant is also known as c.980delC (p.F213fsX232) in the literature. ClinVar contains an entry for this variant (Variation ID: 4540). |
OMIM | RCV000004798 | SCV000024974 | pathogenic | Congenital generalized lipodystrophy type 2 | 2001-08-01 | no assertion criteria provided | literature only | |
Inherited Neuropathy Consortium Ii, |
RCV003311643 | SCV004011986 | uncertain significance | Berardinelli-Seip congenital lipodystrophy | 2016-01-06 | no assertion criteria provided | literature only |